Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1989 1
1990 1
1992 1
1994 2
1995 1
1996 1
1998 1
1999 1
2000 3
2001 4
2002 1
2003 1
2004 6
2005 4
2006 9
2007 5
2008 9
2009 10
2010 3
2011 1
2012 3
2014 3
2015 1
2016 1
2017 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Results by year
Filters applied: . Clear all
Page 1
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.
Donawho CK, Luo Y, Luo Y, Penning TD, Bauch JL, Bouska JJ, Bontcheva-Diaz VD, Cox BF, DeWeese TL, Dillehay LE, Ferguson DC, Ghoreishi-Haack NS, Grimm DR, Guan R, Han EK, Holley-Shanks RR, Hristov B, Idler KB, Jarvis K, Johnson EF, Kleinberg LR, Klinghofer V, Lasko LM, Liu X, Marsh KC, McGonigal TP, Meulbroek JA, Olson AM, Palma JP, Rodriguez LE, Shi Y, Stavropoulos JA, Tsurutani AC, Zhu GD, Rosenberg SH, Giranda VL, Frost DJ. Donawho CK, et al. Among authors: giranda vl. Clin Cancer Res. 2007 May 1;13(9):2728-37. doi: 10.1158/1078-0432.CCR-06-3039. Clin Cancer Res. 2007. PMID: 17473206 Free article.
Optimal two-stage designs for exploratory basket trials.
Zhou H, Liu F, Wu C, Rubin EH, Giranda VL, Chen C. Zhou H, et al. Among authors: giranda vl. Contemp Clin Trials. 2019 Oct;85:105807. doi: 10.1016/j.cct.2019.06.021. Epub 2019 Jun 29. Contemp Clin Trials. 2019. PMID: 31260789
PARP inhibitors attenuate chemotherapy-induced painful neuropathy.
Brederson JD, Joshi SK, Browman KE, Mikusa J, Zhong C, Gauvin D, Liu X, Shi Y, Penning TD, Shoemaker AR, Giranda VL. Brederson JD, et al. Among authors: giranda vl. J Peripher Nerv Syst. 2012 Sep;17(3):324-30. doi: 10.1111/j.1529-8027.2012.00413.x. J Peripher Nerv Syst. 2012. PMID: 22971094
Chkl binds and phosphorylates BAD protein.
Han EK, Butler C, Zhang H, Severin JM, Qin W, Holzman TF, Gubbins EJ, Simmer RL, Rosenberg S, Giranda VL, Ng SC, Luo Y. Han EK, et al. Among authors: giranda vl. Anticancer Res. 2004 Nov-Dec;24(6):3907-10. Anticancer Res. 2004. PMID: 15736430 Free article.
Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma.
Middleton MR, Friedlander P, Hamid O, Daud A, Plummer R, Falotico N, Chyla B, Jiang F, McKeegan E, Mostafa NM, Zhu M, Qian J, McKee M, Luo Y, Giranda VL, McArthur GA. Middleton MR, et al. Among authors: giranda vl. Ann Oncol. 2015 Oct;26(10):2173-9. doi: 10.1093/annonc/mdv308. Epub 2015 Jul 22. Ann Oncol. 2015. PMID: 26202595 Free article. Clinical Trial.
Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitors.
Zhang Q, Xia Z, Mitten MJ, Lasko LM, Klinghofer V, Bouska J, Johnson EF, Penning TD, Luo Y, Giranda VL, Shoemaker AR, Stewart KD, Djuric SW, Vasudevan A. Zhang Q, et al. Among authors: giranda vl. Bioorg Med Chem Lett. 2012 Dec 15;22(24):7615-22. doi: 10.1016/j.bmcl.2012.10.009. Epub 2012 Oct 11. Bioorg Med Chem Lett. 2012. PMID: 23103095
74 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page